Author:
Sun W. L.,Walder A.,Fiegl Michael
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. List A, Kurtin S and Roe DJ et al. (2005). Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med 352: 549–557
2. Darabi K, Kantamnei S, Wiernik PH. Lenalidomide-induced warm autoimmune hemolytic anemia. J Clin Oncol, 24: e59, 2006.
3. Sun WL, Koeck L, Walder A, et al. Successful treatment of MDS with lenalidomide, complicated by transient autoimmune hemolysis. Anna Hematol, Epub ahead of print
4. Faderl S, Rai K and Gribben J et al. (2006). Phase II study of single-agent Bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia. Cancer 107: 916–924
5. Novaretti MCZ, Fonseca GHH and Conchon M et al. (2003). First case of immune- mediated haemolytic anaemia associated to imatinib mesylate. Eur J Haematol 71: 455–458
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献